Health

What are corporate VC managers looking for when hiring? A selection of industry figures tell GCV it isn't just dealmakers, but intellectually curious team players and go-getters.

Lockheed Martin doubled the size of its venture arm to $400m while Ingevity, Geely, SKC and Daishin participated in Nexeon’s $170m series A round.

Xiamen C&D took part in OriCell Therapeutics’ $120m series B round while Shopify provided $100m in funding for Klaviyo.

These are the spinouts that caught our eye over the past month. Here's why they should be on your radar, too.

Social Leverage Acquisition Corp I will acquire AMD and ConsenSys-backed W3BCloud while China Life took part in a $300m round for Taibang Biologic.

Varian Medical Systems has hired Tali Hirsch, formerly venture investment director at Fresenius Medical Care North America, as director of strategy and corporate development.

Actis is set to acquire a majority stake in Mitsui and Equinor-backed Yellow Door Energy while GMO, Yara International and Digital Garage all backed Jai Kisan's $50m series B round.

Qualified psychiatrist Ben Robbins is the third general partner on GV's life science investment team having joined the unit eight years ago.

For corporate venturers, is it better to invest directly from a corporation’s balance sheet or from a stand-alone fund?

Innovation seems threatening to legacy thinking in the region, preventing corporates from going into high-performance mode.